These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
367 related articles for article (PubMed ID: 9482414)
1. Treatment of children with peripheral primitive neuroectodermal tumor or extraosseous Ewing's tumor with Ewing's-directed therapy. Gururangan S; Marina NM; Luo X; Parham DM; Tzen CY; Greenwald CA; Rao BN; Kun LE; Meyer WH J Pediatr Hematol Oncol; 1998; 20(1):55-61. PubMed ID: 9482414 [TBL] [Abstract][Full Text] [Related]
2. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing's sarcoma and primitive neuroectodermal tumor of bone. Grier HE; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Miser JS N Engl J Med; 2003 Feb; 348(8):694-701. PubMed ID: 12594313 [TBL] [Abstract][Full Text] [Related]
3. Treatment of metastatic Ewing's sarcoma or primitive neuroectodermal tumor of bone: evaluation of combination ifosfamide and etoposide--a Children's Cancer Group and Pediatric Oncology Group study. Miser JS; Krailo MD; Tarbell NJ; Link MP; Fryer CJ; Pritchard DJ; Gebhardt MC; Dickman PS; Perlman EJ; Meyers PA; Donaldson SS; Moore S; Rausen AR; Vietti TJ; Grier HE J Clin Oncol; 2004 Jul; 22(14):2873-6. PubMed ID: 15254055 [TBL] [Abstract][Full Text] [Related]
4. Ewing's sarcoma and primitive neuroectodermal tumor in adults: are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children? Verrill MW; Judson IR; Harmer CL; Fisher C; Thomas JM; Wiltshaw E J Clin Oncol; 1997 Jul; 15(7):2611-21. PubMed ID: 9215832 [TBL] [Abstract][Full Text] [Related]
5. Ifosfamide plus etoposide in newly diagnosed Ewing's sarcoma of bone. Meyer WH; Kun L; Marina N; Roberson P; Parham D; Rao B; Fletcher B; Pratt CB J Clin Oncol; 1992 Nov; 10(11):1737-42. PubMed ID: 1403056 [TBL] [Abstract][Full Text] [Related]
6. How effective is dose-intensive/myeloablative therapy against Ewing's sarcoma/primitive neuroectodermal tumor metastatic to bone or bone marrow? The Memorial Sloan-Kettering experience and a literature review. Kushner BH; Meyers PA J Clin Oncol; 2001 Feb; 19(3):870-80. PubMed ID: 11157041 [TBL] [Abstract][Full Text] [Related]
8. Very-high-dose short-term chemotherapy for poor-risk peripheral primitive neuroectodermal tumors, including Ewing's sarcoma, in children and young adults. Kushner BH; Meyers PA; Gerald WL; Healey JH; La Quaglia MP; Boland P; Wollner N; Casper ES; Aledo A; Heller G J Clin Oncol; 1995 Nov; 13(11):2796-804. PubMed ID: 7595741 [TBL] [Abstract][Full Text] [Related]
9. Ewing's sarcoma and primitive neuroectodermal tumour in adults: single-centre experience in The Netherlands. Smorenburg CH; van Groeningen CJ; Meijer OW; Visser M; Boven E Neth J Med; 2007 Apr; 65(4):132-6. PubMed ID: 17452761 [TBL] [Abstract][Full Text] [Related]
10. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: end results of POG #8346. Pediatric Oncology Group. Donaldson SS; Torrey M; Link MP; Glicksman A; Gilula L; Laurie F; Manning J; Neff J; Reinus W; Thompson E; Shuster JJ Int J Radiat Oncol Biol Phys; 1998 Aug; 42(1):125-35. PubMed ID: 9747829 [TBL] [Abstract][Full Text] [Related]
11. Second malignancies after treatment for Ewing's sarcoma: a report of the CESS-studies. Dunst J; Ahrens S; Paulussen M; Rübe C; Winkelmann W; Zoubek A; Harms D; Jürgens H Int J Radiat Oncol Biol Phys; 1998 Sep; 42(2):379-84. PubMed ID: 9788419 [TBL] [Abstract][Full Text] [Related]
12. No advantages in the addition of ifosfamide and VP-16 to the standard four-drug regimen in the maintenance phase of neoadjuvant chemotherapy of Ewing's sarcoma of bone: results of two sequential studies. Bacci G; Picci P; Ruggieri P; Ferrari S; Mercuri M; Fabbri N; Rosito P; Barbieri E; Ferraro A; Casadei R J Chemother; 1993 Aug; 5(4):247-57. PubMed ID: 8229153 [TBL] [Abstract][Full Text] [Related]
13. Adults with Ewing's sarcoma/primitive neuroectodermal tumor: adverse effect of older age and primary extraosseous disease on outcome. Baldini EH; Demetri GD; Fletcher CD; Foran J; Marcus KC; Singer S Ann Surg; 1999 Jul; 230(1):79-86. PubMed ID: 10400040 [TBL] [Abstract][Full Text] [Related]
14. Chemotherapy dose-intensification for pediatric patients with Ewing's family of tumors and desmoplastic small round-cell tumors: a feasibility study at St. Jude Children's Research Hospital. Marina NM; Pappo AS; Parham DM; Cain AM; Rao BN; Poquette CA; Pratt CB; Greenwald C; Meyer WH J Clin Oncol; 1999 Jan; 17(1):180-90. PubMed ID: 10458232 [TBL] [Abstract][Full Text] [Related]
15. [Primitive cutaneous Ewing's sarcoma: a diagnostic and therapeutic dilemma]. Delaplace M; Mélard P; Perrinaud A; Goré C; Vergier B; Machet L Ann Dermatol Venereol; 2011 May; 138(5):395-8. PubMed ID: 21570564 [TBL] [Abstract][Full Text] [Related]
16. High-dose induction chemoradiotherapy followed by autologous bone marrow transplantation as consolidation therapy in rhabdomyosarcoma, extraosseous Ewing's sarcoma, and undifferentiated sarcoma. Boulad F; Kernan NA; LaQuaglia MP; Heller G; Lindsley KL; Rosenfield NS; Abramson SJ; Gerald WL; Small TN; Gillio AP; Gulati SC; O'Reilly RJ; Ghavimi F J Clin Oncol; 1998 May; 16(5):1697-706. PubMed ID: 9586881 [TBL] [Abstract][Full Text] [Related]
17. Ifosfamide-containing chemotherapy in Ewing's sarcoma: The Second United Kingdom Children's Cancer Study Group and the Medical Research Council Ewing's Tumor Study. Craft A; Cotterill S; Malcolm A; Spooner D; Grimer R; Souhami R; Imeson J; Lewis I J Clin Oncol; 1998 Nov; 16(11):3628-33. PubMed ID: 9817284 [TBL] [Abstract][Full Text] [Related]